EMA Picks Valproate For First Public Hearing On Safety Of Marketed Medicines

 
• By Vibha Sharma
  
Microphones
EMA’s first ever public hearing will focus on anti-epileptic drug valproate. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography